These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2163560

  • 1. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.
    Bürki F, Rossmanith W, Nowotny N, Pallan C, Möstl K, Lussy H.
    Vet Q; 1990 Apr; 12(2):80-6. PubMed ID: 2163560
    [Abstract] [Full Text] [Related]

  • 2. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
    Burrows R, Goodridge D, Denyer MS.
    Vet Rec; 1984 Apr 14; 114(15):369-74. PubMed ID: 6328728
    [Abstract] [Full Text] [Related]

  • 3. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.
    Bresgen C, Lämmer M, Wagner B, Osterrieder N, Damiani AM.
    Vet Microbiol; 2012 Nov 09; 160(1-2):9-16. PubMed ID: 22633483
    [Abstract] [Full Text] [Related]

  • 4. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT, Allen GP.
    Dev Biol Stand; 1982 Nov 09; 52():493-8. PubMed ID: 6299858
    [Abstract] [Full Text] [Related]

  • 5. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
    Heldens JG, Hannant D, Cullinane AA, Prendergast MJ, Mumford JA, Nelly M, Kydd JH, Weststrate MW, van den Hoven R.
    Vaccine; 2001 Jul 20; 19(30):4307-17. PubMed ID: 11457558
    [Abstract] [Full Text] [Related]

  • 6. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.
    Patel JR, Bateman H, Williams J, Didlick S.
    Vet Microbiol; 2003 Jan 02; 91(1):23-39. PubMed ID: 12441229
    [Abstract] [Full Text] [Related]

  • 7. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH, Wattrang E, Hannant D.
    Vet Immunol Immunopathol; 2003 Dec 15; 96(3-4):207-17. PubMed ID: 14592733
    [Abstract] [Full Text] [Related]

  • 8. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR, Földi J, Bateman H, Williams J, Didlick S, Stark R.
    Vet Microbiol; 2003 Mar 20; 92(1-2):1-17. PubMed ID: 12488066
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N.
    Vaccine; 2006 Apr 24; 24(17):3636-45. PubMed ID: 16513225
    [Abstract] [Full Text] [Related]

  • 10. Vaccination of mares against equine herpesvirus-1.
    Pickles AC.
    Vet Rec; 1992 Feb 22; 130(8):167-8. PubMed ID: 1314446
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Equine herpesvirus.
    Vet Rec; 1989 May 13; 124(19):519. PubMed ID: 2547266
    [No Abstract] [Full Text] [Related]

  • 13. Towards a vaccine against equine herpesvirus 1.
    Sabine M, Whalley JM.
    Aust Vet J; 1989 Dec 13; 66(12):403-4. PubMed ID: 2559691
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
    Eaglesome MD, Henry JN, McKnight JD.
    Can Vet J; 1979 May 13; 20(5):145-7. PubMed ID: 226261
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1.
    Bürki F, Nowotny N, Oulehla J, Schmehlik O, Möstl K, Pallan C, Rossmanith E.
    Zentralbl Veterinarmed B; 1991 Aug 13; 38(6):432-40. PubMed ID: 1659067
    [Abstract] [Full Text] [Related]

  • 18. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
    Mumford JA, Bates J.
    Vet Rec; 1984 Apr 14; 114(15):375-81. PubMed ID: 6328729
    [Abstract] [Full Text] [Related]

  • 19. [Year-round antibody profile of groups of horses of a herd kept in isolation after differently terminating use of an experimental viral combination vaccine].
    Bürki F, Nowotny N, Hofer A.
    Dtsch Tierarztl Wochenschr; 1991 Mar 14; 98(3):82-9. PubMed ID: 1646100
    [Abstract] [Full Text] [Related]

  • 20. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL, Babasyan S, Rollins A, Freer H, Wimer CL, Perkins GA, Raza F, Osterrieder N, Wagner B.
    J Virol; 2019 Nov 15; 93(22):. PubMed ID: 31462575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.